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Background: Bradykinin type 2 receptor (B2BRK) genotype was reported to be associated with changes in the
left-ventricular mass as a response to aerobic training, as well as in the regulation of the skeletal muscle
performance in both athletes and non-athletes. However, there are no reports on the effect of B2BRK 9-bp
polymorphism on the response of the skeletal muscle to strength training, and our aim was to determine the
relationship between the B2BRK SNP and triceps brachii functional and morphological adaptation to programmed
physical activity in young adults.
Methods: In this 6-week pretest-posttest exercise intervention study, twenty nine healthy young men (21.5 ± 2.7 y,
BMI 24.2 ± 3.5 kg/m2) were put on a 6-week exercise protocol using an isoacceleration dynamometer (5 times a
week, 5 daily sets with 10 maximal elbow extensions, 1 minute rest between sets). Triceps brachii muscle volumes
were assessed by using magnetic resonance imaging before and after the strength training. Bradykinin type 2
receptor 9 base pair polymorphism was determined for all participants.
Results: Following the elbow extensors training, an average increase in the volume of both triceps brachii was
5.4 ± 3.4% (from 929.5 ± 146.8 cm3 pre-training to 977.6 ± 140.9 cm3 after training, p<0.001). Triceps brachii volume
increase was significantly larger in individuals homozygous for −9 allele compared to individuals with one or two
+9 alleles (−9/-9, 8.5 ± 3.8%; vs. -9/+9 and +9/+9 combined, 4.7 ± 4.5%, p < 0.05). Mean increases in endurance
strength in response to training were 48.4 ± 20.2%, but the increases were not dependent on B2BRK genotype
(−9/-9, 50.2 ± 19.2%; vs. -9/+9 and +9/+9 combined, 46.8 ± 20.7%, p > 0.05).
Conclusions: We found that muscle morphological response to targeted training – hypertrophy – is related to
polymorphisms of B2BRK. However, no significant influence of different B2BRK genotypes on functional muscle
properties after strength training in young healthy non athletes was found. This finding could be relevant, not only
in predicting individual muscle adaptation capacity to training or sarcopenia related to aging and inactivity, but
also in determining new therapeutic strategies targeting genetic control of muscle function, especially for
neuromuscular disorders that are characterized by progressive adverse changes in muscle quality, mass, strength
and force production (e.g., muscular dystrophy, multiple sclerosis, Parkinson’s disease).
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Skeletal muscle adaptation to programmed physical ac-
tivity includes changes in muscle function and morpho-
logical properties [1,2]. The extent of this specific
adaptation is influenced by multiple factors, such as gen-
etic predisposition, hormonal influences, the neural
component, muscle fiber composition, characteristics of
training (frequency, intensity and duration), and others
[1,3]. A number of genes have been discovered that are
likely to influence specific performance both in athletes
and non-athletes. In the decade after the gene for angio-
tensin converting enzyme (ACE) was first proposed to
be a ‘human gene for physical performance’ [4,5], there
have been numerous studies examining the effects of
ACE and other genes on athletic status [6,7]. In several
cases, these gene variants have been associated with aer-
obic capacity and muscle fiber composition as endurance
related traits [6,7].
Bradykinin is a nonapeptide that acts as a potent vaso-
dilator [8]. Within skeletal muscle, bradykinin promotes
glucose uptake and alters muscle blood flow [9-12].
Bradykinin exerts many of its effects by binding to
bradykinin type 2 receptor (B2BRK) [13]. Transcriptional
gene activity and mRNA levels of B2BRK are influenced
by the nine base pair (9-bp) repeat fragment in exon 1.
Lower transcriptional activity and lower mRNA levels
are detected in the presence of the 9-bp fragment (+9),
while the absence of the 9-bp fragment (−9) leads to
higher transcriptional activity and mRNA levels [14,15].
Several studies have implicated B2BRK in the adapta-
tion to exercise and in the regulation of the skeletal
muscle performance. Response to a 10-week training
programme resulted in changes in the left-ventricular
mass that were greatest for the carriers of the +9 allele,
and smallest for the −9 homozygotes [16]. Bradykinin −9
allele was also associated with greater skeletal muscle
metabolic efficiency in both athletes and non-athletes
[17]. However, there are no reports on the effect of
B2BRK 9-bp polymorphism on the response of the skel-
etal muscle to strength training. We have recently
reported the morphological changes of triceps brachii
muscle as a result of 6 and 12-week strength training
protocols, and the correlation of muscle volume with
changes in functional muscle properties [18,19]. Al-
though a correlation was discovered between morpho-
logical and functional properties of muscles, there was
no significant correlation between changes in muscle
volume and strength as a result of the resistance train-
ing. Also, participants showed different range in strength
and volume increase after maximal training stimulus ap-
plied, which additionally implied the possible influence
of genetic predisposition to muscle adaptation capacity.
In accordance with these data and previous studies
that had found association between bradykinin type 2receptor (B2BRK) and muscle hypertrophy, we followed
triceps brachii morphological and functional changes as
a result of strength training. We chose to train elbow
extensors, since we could isolate extension movement
and precisely measure the strength of each contraction.
Also, these are not postural muscles and therefore we
could control training stimulus more closely then with
other muscles (for example, leg muscles). Since apparent
hypertrophy occurs after first four weeks of training, our
aim was to follow-up this initial hypertrophic response
to the training stimulus.
The aim of this study was to determine the influence
of bradykinin type 2 receptor 9-bp polymorphism on the
response of triceps brachii adaptation to a 6-week train-
ing of elbow extensors.Methods
Subjects
Twenty nine healthy young Caucasian men (21.5 ± 2.7 y,
body mass (BM) 80.2 ± 12.6 kg, body height (BH)
181.7 ± 7.2 cm, body mass index (BMI) 24.2 ± 3.5 kg/m2),
who did not take part in any formal resistance exercise re-
gime for 6 months prior to starting a 6-week exercise
protocol, volunteered for this study. They were all
healthy, according to the anamnestic data. All subjects
were given an oral and written explanation of the study
before signing a written informed consent form.
The study was approved by the Research Ethics Com-
mittee of the Medical School, University of Novi Sad,
and the investigation was performed according to the
principles outlined in the Declaration of Helsinki.Training protocol and triceps brachii muscle strength
measurements
Elbow extensors training was performed on the isoacce-
leration dynamometer Concept 2 Dyno (Concept 2, Inc.
Morrisville, Vermont, USA). The testing–training pro-
cedure had been introduced to the participants one day
prior to the training in order to make them familiar with
the procedure. The training protocol lasted for 6 weeks,
with a frequency of five sessions per week (5 consecutive
training days during a working week, and two days with-
out training during the weekend – this protocol was the
same for all participants). Each training session included
five sets of 10 maximal elbow extensions following 15
minutes of a general warm-up. A one minute resting
period was allowed between each set. Each contraction
was performed in the sitting bench press position with
the full elbow extension of both arms against the resist-
ance to maintain a central acceleration during the whole
range of movement, as previously reported [18,19]. All
participants were regularly attending their sessions
throughout the whole training.
Figure 1 Two images of a slice at mid-humerus in a participant
before and after 6-week strength training. The manually outlined
cross-sectional areas (CSA) of m.triceps brachii show significant
increase in muscle area – hypertrophy as a result of elbow extensors
training (before training CSA1 = 27.3 cm
2, and after training
CSA2 = 29.5 cm
2).
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plished with the constant supervision of training series
by the investigator. We instructed participants how to
perform contractions, controlled all the movements dur-
ing the training and we asked them to perform all exten-
sions correctly and with maximal strength. We were
encouraging them verbally during the entire process.
They were always measured in a group so they could ob-
serve training sessions preceding their own, which
potentiated a competitive spirit among them.
The isoacceleration dynamometer uses constant accel-
eration throughout the whole range of movement – the
measured load and muscle strength represent the aver-
age value achieved during the whole movement dur-
ation. Therefore, the isoacceleration dynamometer
which was used in this study allowed a precise measure-
ment of each contraction workload and strength output.
The participants were performing contractions with
strength which they personally perceived to be their
maximal strength, and load and strength were measured
for every single contraction, which enabled us to exactly
measure individual and total workload and strength dur-
ing a series of contractions. Therefore, the load was indi-
vidually applied and maximal in each contraction,
according to the personal perception of each participant.
The training load was not dosed; it was the result of the
participants’ maximal muscle strength – therefore indi-
vidually adjusted.
Strength of each elbow extension was recorded during
the training sessions and used in the subsequent ana-
lysis. Maximal strength (MS) was defined as the highest
scored result in Newtons (N), while endurance muscle
strength (ES) of both triceps brachii muscles was defined
as the average value of all 50 contractions expressed in
Newtons (N). Percentage decline of average values of the
fifth series in relation to the first one was defined as fa-
tigue rate (FR). All three strength parameters were mea-
sured on the first and the last (30th) day of training.
Muscle volume measurements
A series of cross-sectional images of the triceps brachii
muscles were obtained by MRI scans with an extremity
coil on the Magnetom Avanto TIM Siemens, 1.5 T
(Siemens, Erlangen, Germany). Мultislice sequences of
T1-weighted, flash (gradient echo) axial images of both
arms were obtained, starting from the humerus head to
the medial epicondils, and each arm was imaged separ-
ately. MRI parameters were: repetition time (TR) – 232
ms, echo time (TE) – 4.76 ms, field of view (FOV) –
162 × 288 mm, and the matrix size – 288 × 512. Slice
thickness was 10 mm with an interslice interval of 3
mm. Data processing was conducted using the Medical
Image Processing, Analysis and Visualization (MIPAV)
software, version 2.6 (Center for Information Technology,National Institutes of Health, Bethesda, MD). The
MIPAV software was used to analyze images on a per-
sonal computer workstation [20]. This program calcu-
lates the surface area (in mm2) of the manually selected
region of interest – ROI (i.e. triceps brachii cross-
sectional area – CSA) in every axial image from the first
section closest to the superior border of the humerus to
a point where the muscle group is no longer reliably dis-
tinguishable [21,22]. Two post-processed images of a
single slice at mid-humerus in a participant, before and
after-training with outlined m.triceps brachii CSAs, are
shown in Figure 1. The same number of sections distal
from the humerus was measured for a particular subject
before and after 6 weeks of training, to ensure identical
measurement replication. All sequences were analyzed
by the same person (JPG). The investigator was blinded
to subject identification, date of scan, and training sta-
tus, as well as their genotypes, in both baseline and after
training analyses. The intra-class correlation coefficient
for repeated measurements was 0.99. Cronbach’s Alpha
(α) - Reliability Coefficient for repeated measures on the
same participant was 0.98 for triceps brachii. The final
muscle volume (Vm) was calculated using the truncated
cone formula, as previously reported [23]. Final muscle
volume used for further calculations was the sum of
both arms triceps brachii muscle volumes. For all parti-
cipants, final volume measurements on MRI were per-
formed three days after the last training session, with
the same protocol applied.
Genotyping
Genomic DNA was isolated from blood collected on
FTA cards (Whatman) using Chelex [24]. In order to
identify 9-bp insertion/deletion polymorphism within the
bradykinin type 2 receptor gene PCR reaction was per-
formed according to a previously reported protocol [25].
Figure 2 Values of two functional parameters in all participants
(N = 29) expressed before and after the training: a) maximal
and endurance strength values in Newtons, and b) fatigue rate
as a percentage of strength decrease. Maximal and endurance
strength showed significantly higher post-training values, while
fatigue rate decreased significantly after strength training of elbow
extensors. However, no significant changes in these parameters
were observed in association with B2BRK genotypes. Legend:
MS – maximal strength; ES – endurance strength; FR – fatigue rate;
N – Newtons. * p < 0.05.
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and reverse (5'– AGTCGCTCCCTGGTACTGC –3')
primers were combined with 1x AmpliTaq Gold buffer
(Applied Biosystems), 3.75 mM MgCl2, 800 uM dNTPs
(Fermentas), 1 U AmpliTaq Gold polymerase (Applied
Biosystems) and genomic DNA. PCR conditions included
initial denaturation at 94°C, followed by 40 cycles of
denaturation at 94°C, annealing at 60°C and elongation at
72°C followed by a final elongation step at 72°C. PCR
products were resolved on 3% agarose gels.
Statistical analysis
All data were presented as mean ± SD unless otherwise
indicated. Hardy-Weinberg equilibrium was tested using
a Chi-square analysis with one degree of freedom. For
the statistical analysis triceps brachii volumes were cal-
culated for each arm, and then combined. The differ-
ences between B2BRK genotypes were determined using
One-way Analysis of Variance (ANOVA) or Student’s
two-tailed t test when appropriate (for comparisons be-
tween −9 homozygotes and two other genotypes com-
bined). When indicated by a significant F value, Tukey’s
test was performed to identify differences between geno-
type groups. Statistical significance was indicated if
p < 0.05. Minimum required sample size for our study
was 5 for both groups, for the following parameters:
number of groups = 2, type I error rate α = 0.05, statis-
tical power 0.8, average value (standard deviation): for
sample one AVE = 68.9 (24.3) cm3; for sample two AVE =
49.4 (46.4) cm3. All calculations were performed using the
Statistica data analysis software (StatSoft).
Results
B2BRK genotype distribution (n = 6 -9/-9, n = 18 -9/+9,
n = 5 +9/+9) was consistent with Hardy-Weinberg equi-
librium. Allele frequencies were 0.52 for −9 allele and
0.48 for +9 allele, which is similar to those previously
reported [14-17]. Pre-training characteristics (age,
weight, height, body mass index) were independent of
B2BRK genotype.
Muscle strength changes
B2BRK genotype did not have any influence on pre-
training maximal or endurance triceps brachii muscle
strength (MS for −9/-9: 623.5 ± 126.5 N vs. -9/+9 and
+9/+9: 671.6 ± 120.6 N; p = 0.19; ES for −9/-9: 426.5 ±
83.3 N vs. -9/+9 and +9/+9: 456.9 ± 108.8 N; p = 0.21)
or post-training triceps brachii strength (MS for −9/-9:
753.9 ± 126.5 N vs. -9/+9 and +9/+9: 795.1 ± 119.6 N;
p = 0.23; ES for −9/-9: 635.3 ± 117.6 N vs. -9/+9 and
+9/+9: 657.8 ± 120.6 N; p = 0.31). Similarly, fatigue rate
showed no significant correlation with B2BRK genotype
(pre-training −9/-9: 41.2 ± 13.4% vs. -9/+9 and +9/+9:
41.3 ± 10.2%; p = 0.49; post-training −9/-9: 15.8 ± 6.6%vs. -9/+9 and +9/+9: 14.9 ± 7.4%; p = 0.38). Mean
increases in functional muscle properties in response to
6 weeks of training were significant (for MS 19.9 ±
11.4%, for ES 48.4 ± 20.2%, and decrease in FR 73.8 ±
10.3%), as presented in Figure 2a and 2b. However,
these changes were not dependent on B2BRK genotype
(p > 0.05).Muscle volume changes
To determine if changes in muscle volume in response
to training were dependent on B2BRK genotype, we
recorded the MRI of the upper arm before and after 6
weeks of training and examined the influence of B2BRK
genotype on muscle gains.
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on B2BRK genotype: -9/-9, 845.7 ± 137.3 cm3; vs. -9/+9
and +9/+9 combined, 950.6 ± 148.7 cm3 (p = 0.17).
Bradykinin polymorphism did not influence post-
training triceps brachii volumes, as well: -9/-9, 914.2 ±
124.5 cm3; vs. -9/+9 and +9/+9 combined, 993.4 ±
147.2 cm3 (p = 0.28).
After 6 weeks of elbow extensors training, an average
increase in the volume of triceps brachii muscle was
5.4 ± 3.4% as pre-training volume increased from 929.5 ±
146.8 cm3 to 977.6 ± 140.9 cm3 after training (p <0.001).
Bradykinin receptor genotype did have an effect on the
extent of the change in triceps brachii volume, both
expressed as difference (ΔV −9/-9, 68.9 ± 24.3cm3; vs.
-9/+9 and +9/+9 combined, 49.4 ± 46.4cm3 (p = 0.04),
and as percentage change (V% -9/-9, 8.5 ± 3.8%; vs.
-9/+9, and +9/+9 combined, 4.7 ± 4.5% (p = 0.03). In-
crease in triceps brachii volume was significantly larger
in individuals homozygous for −9 allele compared to
individuals with one or two +9 alleles.
Discussion
The aim of this study was to determine the possible in-
fluence of bradykinin type 2 receptor 9 base pair poly-
morphism on triceps brachii muscles hypertrophy as a
result of six weeks of self-perceived maximal elbow
extensors strength training. Since muscle adaptation is
in part influenced by heritability, we wanted to investi-
gate the possible influence of bradykinin type 2 receptor
gene variants on skeletal muscle adaptation capacity in
young adults.
The volume of upper arms elbow extensors increased
significantly, by 5.4 ± 3.4%, as a result of a 6-week
strength training of our participants. These data are in
line with other researchers, since skeletal muscle hyper-
trophy is a part of muscle adaptation to increased phys-
ical activity levels. Different resistance training
protocols have been shown to present a variety of exer-
cise demands resulting in adaptations which are specific
to the exercise program used [1-3]. Andersen et al.
found that m.quadriceps femoris CSA at mid-femur
increased by 10% after 3 months resistance training [2].
Abe et al. found relative increases in upper (12% - 21%)
and lower (7% - 9%) body muscle thickness in men and
10% - 31% and 7% - 8% in women, respectively [1]. This
was after 12 weeks of resistance training, three times
per week (six dynamic resistance exercises to fatigue
using 8–12 1-repetition maximum – 1RM) in untrained
participants [1].
Skeletal muscle adaptation capacity depends on nu-
merous factors, and the genetic predisposition is cer-
tainly one of them. There are number of reports in
literature regarding influences of different genes and
their polymorphism on skeletal muscle morphologicaland functional adaptation. In our study, we used MRI to
evaluate muscle hypertrophy response to training stimu-
lus, which was maximal according to participants’ per-
sonal perception, and investigated if there was an
influence of bradykinin type 2 receptor variants on the
extent of hypertrophy and strength gains.
We found that the presence of two −9 alleles of the
B2BRK leads to significantly higher skeletal muscle
hypertrophy after a short-term strength training, com-
pared to the presence of one or two +9 alleles. Mon-
tgomery’s group reported that heart muscle hypertrophy
is more extensive in individuals with +9/+9 genotype
variant, when completing a 10-week physical training
protocol [5]. They showed that genotypes that lead to
lower bradykinin type 2 receptor concentrations (B2BRK
+9/+9) correlate with greater cardiac growth response to
increased physical activity. Our data suggest that skeletal
muscle responds differently from cardiomyocytes to the
increased load. Although pre-training triceps brachii
muscle volume and average strength did not appear to
be influenced by the bradykinin 9-bp polymorphism, tri-
ceps brachii muscle volume increased significantly more
in individuals with −9/-9 genotype after 6 weeks of tar-
geted training.
We discovered a significant change in muscle func-
tional properties as a result of strength training. Max-
imal muscle strength increased by 19.9%, endurance by
48.4%, and fatigue rate decreased by 73.8%. However,
bradykinin polymorphism did not correlate with the
changes in triceps brachii muscle strength, endurance
and fatigue, as a result of a 6-week training. There are
only a few reports in the literature on the relationship
between polymorphism in the bradykinin type 2 receptor
and the functional capacity of skeletal muscles. Williams
et al. reported that common 9-bp variation in the B2BRK
is associated with efficiency of skeletal muscle contrac-
tion (delta efficiency) in both athletes and non-athletes
[17]. On the other hand, Hopkinson and associates
reported that the genotype with reduced B2BRK expres-
sion (+9) is associated with quadriceps strength in
chronic obstructive pulmonary diseases [26].
A possible explanation of our results concerning
muscle strength, which are not in line with some other
researchers, may be found in the fact that there is a var-
iety of functional muscle properties that can be assessed
as a result of specific adaptation to training, and we fol-
lowed only some of them. It is known that muscle
strength is not completely dependent on muscle size,
and there are a number of factors that influence
strength, endurance, or fatigue, and their change after
training, especially in the first 4–6 weeks of programmed
physical activity.
Higher transcriptional activity and higher mRNA
levels have been associated with the B2BRK −9 allele.
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glucose uptake in the skeletal muscle during exercise
[9,27]. Activation of bradykinin type 2 receptor could
also result in an increased concentration of inositol tri-
phosphate, which gives rise to increased calcium con-
centration within the cell [28,29]. Bradykinin has also
been shown to induce the production of nitric oxide in
the skeletal muscle [30], which can reduce oxygen con-
sumption in skeletal muscle mitochondria [31]. It can be
expected that the higher number of bradykinin type 2
receptors could lead to increased stimulation of skeletal
muscle cells when exposed to training stimulus. It is all
mediated throughout the increased substrate intake and
therefore throughout the increased energy production,
which altogether stimulates cell activity and promotes
hypertrophic stimulation mechanisms.
Our results suggest that higher bradykinin receptor
levels present in individual homozygous for −9 allele of
the B2BRK gene may be advantageous in the adaptation
of the skeletal muscle to the demands of the training.
Ability to gain muscle is especially important in later
decades of life, when loss of muscle bulk correlates with
poorer quality of life and higher mortality [32]. Identify-
ing gene polymorphisms that influence muscle respon-
siveness to training could help identify those with higher
probability of muscle loss, as well as aid in designing
more tailored approaches to training. This finding could
be relevant, not only in predicting individual muscle
adaptation capacity to training or sarcopenia related to
aging and inactivity, but also in determining new thera-
peutic strategies targeting genetic control of muscle
function, especially for neuromuscular disorders that are
characterized by progressive adverse changes in muscle
quality, mass, strength and force production (e.g., mus-
cular dystrophy, multiple sclerosis, Parkinson’s disease).
Certain limitations need to be considered in the
present study. The number of participants was small, es-
pecially in a +9/+9 genotype group (only five), and
therefore we presented our data set divided into two
groups only – one without, and the second with the
presence of one or both +9 allele. The reason for this
was the fact that the presence of both −9 alleles leads to
higher expression of bradykinin receptors, compared to
other two genotype combinations. The exercise used in
the training could partially engage some other muscles
in this area (etc. deltoideus and pectoralis). However, the
specific position which the participant had taken (up-
right seated position, with elbows close to the trunk)
and the fact that every session was closely monitored by
the investigator, allow us to assume that triceps stimula-
tion was equal during the training process, and that the
participation of other muscles was not significant. The
aim was not to trace a single trait, its’ distribution in
population, nor its’ association with some functional ormorphological properties of skeletal muscles. We wanted
to explore the possible influence of B2BRK polymorph-
ism on skeletal muscle adaptation capacity after a pro-
grammed physical activity protocol, and these changes
were followed in the same participant using precise mea-
surements. Also, by applying the identical training and
testing procedures in all participants, we additionally
diminished the possibility that strength values or their
increase were overestimated in some volunteers.Conclusions
Six week maximal, self-perceived strength training of
elbow extensors led to significant adaptation changes of
triceps brachii muscles. Elbow extensors of −9/-9 B2BRK
homozygous individuals exhibited significantly higher
hypertrophy compared to those with −9/+9 or +9/+9
B2BRK variants. However, there was no significant influ-
ence of different B2BRK genotypes on functional muscle
properties after strength training in young healthy non
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